When the Laboratory  receives an ATPF -CPR for  a Sample  for which Adverse Analytical Finding(s) (AAF) have been reported for other Prohibited Substance(s)  or Method(s) , the  Laboratory  shall consult the Testing Authority  (or Results Management Authority , if different) about the need to conduct the CP for the Markers  of the steroid profile.